High-throughput tissue microarray analysis of 11qI3 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer

Journal of Pathology

Volumn 201, Issue 4, 2003, Pages 603-608

  Zaharieva, Boriana ^a   Simon, Ronald ^b   Diener, Pierre Andre ^c   Ackermann, Daniel ^c   Maurer, Robert ^d   Alund, Göran ^d   Knönagel, Hartmut ^e   Rist, Marcus ^f   Wilber, Kim ^g   Hering, Franz ^h   Schönenberger, Andreas ⁱ   Flury, Renata ^j   Jäger, Peter ^j   Fehr, Jean Luc ^k   Mihatsch, Michael J ^b   Gasser, Thomas ^l   Sauter, Guido ^b   Toncheva, Draga I ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY OF BASEL   (Switzerland)

^c CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^d TRIEMLI HOSPITAL   (Switzerland)

^e Spital Limmattal   (Switzerland)

^f Clara Hospital   (Switzerland)

^g ABBOTT LABORATORIES   (United States)

^h Kantonsspital Baden   (Switzerland)

ⁱ Cantonal Hospital Munsterlingen   (Switzerland)

^j CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^k Hospital of Schaffhausen   (Switzerland)

^l Kantonsspital Liestal   (Switzerland)

more..

Author keywords

11q13 amplicon; Bladder cancer; Cyclin D1; Fluorescence in situ hybridization (FISH); Tissue microchips

Indexed keywords

CORTACTIN; CYCLIN D1; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; ONCOPROTEIN;

ADULT; AGED; AMPLICON; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 11Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE LOCATION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC DISTANCE; GENETIC SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PRIORITY JOURNAL; PROTEIN MICROARRAY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CHROMOSOMES, HUMAN, PAIR 11; CORTACTIN; CYCLIN D1; DNA, NEOPLASM; FEMALE; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; FIBROBLAST GROWTH FACTORS; GENE AMPLIFICATION; GENES, BCL-1; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENES; PHENOTYPE; PROGNOSIS; PROTO-ONCOGENE PROTEINS; URINARY BLADDER NEOPLASMS;

EID: 10744232226     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1481     Document Type: Article

References (27)

1. Richter J, Beffa L, Wagner U, et al. Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 1998; 153: 1615-1621.
2. Simon R, Burger H, Brinkschmidt C, Bocker W, Hertle L, Terpe HJ. Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol 1998; 185: 345-351.
3. Richter J, Wagner U, Schraml P, et al. Chromosomal imbalances are associated with a high risk of progression in early invasive (pT1) urinary bladder cancer. Cancer Res 1999; 59: 5687-5691.
4. Vooter C, Joos S, Bringuer P, et al. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Am J Pathol 1995; 146: 1341-1354.
5. Hovey R, Chu L, Balazs M, et al. Genetic alterations in primary bladder cancers and their metastases. Cancer Res 1998; 58: 3555-3560.
6. Donnellan R, Chetty R. Cyclin D1 and human neoplasia. Mol Pathol 1998; 51: 1-7.
7. van Damme H, Brok H, Schuuring-Scholtes E, Schuuring E. The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overstatement and post-translational modification. J Biol Chem 1997; 272: 7374-7380.
8. Wang MB, Alavi S, Engstrom M, et al. Detection of chromosome 11q13 amplification in head and neck cancer using fluorescence in situ hybridization. Anticancer Res 1999; 19: 925-931.
9. Seshadri R, Lee CS, Hui R, McCaul K, Horsfall DJ, Sutherland RL. Cyclin D1 amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis. Clin Cancer Res 1996; 2: 1177-1184.
10. Hui R, Campbell DH, Lee CS, et al. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 1997; 15: 1617-1623.
11. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJ. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 1992; 7: 355-361.
12. Sauter G, Moch H, Gudat F, et al. Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH). Verh Dtsch Ges Pathol 1993; 77: 247-251.
13. Sato K, Kato T, Moriyama M. Int-2 and c-erbB-2 gene amplification in urological cancers. Nippon Hinyokika Gakkai Zasshi 1992; 83: 1957-1963.
14. Bringuier PP, Tamimi Y, Schuuring E, Schalken J. Statement of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification. Oncogene 1996; 12: 1747-1753.
15. Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overstatement in urinary bladder cancer. Am J Pathol 2000; 157: 787-794.
16. Mostofi F, Sobin L, Torloni H. Histological Typing of Urinary Bladder Tumors. International Classification of Tumors. No 10, vol 10. World Health Organization: Geneva, 1973.
17. UICC TNM Classification of Malignant Tumors (4th edn). Springer: Berlin, 1992.
18. Kaplan E, Maier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
19. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 1998; 4: 844-847.
20. Schraml P, Kononen J, Bubendorf L, et al. Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 1999; 5: 1966-1975.
21. Nocito A, Kononen L Kallioniemi OP, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001; 94: 1-5.
22. Torhorst J, Bucher C, Kononen J, et al. Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 2001; 159: 2249-2256.
23. Simon R, Richter J, Wagner U, et al. High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res 2001; 61: 4514-4519.
24. Simon R, Struckmarm K, Schraml P, et al. Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene 2002; 21: 2476-2483.
25. Patel AS, Schechter GL, Wasilenko WJ, Somers KD. Overexpression of EMS1/cortactin in NIH3T3 fibroblasts causes increased cell motility and invasion in vitro. Oncogene 1998; 16: 3227-3232.
26. Watters AD, Latif Z, Forsyth A, et al. Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer. Br J Cancer 2002; 87: 654-658.
27. Wagner U, Suess K, Luginbuhl T, et al. Cyclin D1 overexpression lacks prognostic significance in superficial urinary bladder cancer. J Pathol 1999; 188: 44-50.